Australia-based radiopharmaceutical company Telix Pharmaceuticals has created a new radionuclide generator that could ...

The system uses a simple radionuclide generator to repeatedly separate thorium-226 from its longer-lived parent isotope, uranium-230. Both of these isotopes emit radioactive alpha particles.

Radionuclides and/or radiopharmaceuticals are prepared in hot labs by nuclear medicine technologists. The molybdenum-technetium 99 Mo/ 99m Tc-generator is used as a primary source in hot labs to ...

Precision Radionuclide Therapy™ is a proprietary treatment that uses highly localized radiation to destroy cancerous tumors by placing a radioactive isotope directly inside the treatment area.

In continuing with this approach, the present CRP seeks to enhance the utilisation of Ga-68, a cyclotron independent, generator produced PET radionuclide. Gallium-68 is a positron emitter with 68 ...

Initiation of Phase 1/2 clinical study of novel peptide-targeted radionuclide therapy and imaging agent targeting fibroblast activation protein (FAP) expected 1H 2021 Will be the first peptide ...

CHENGDU, China, March 25, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company has received a clinical trial notice approving the ...

Buscar noticias, acciones... Mercados Mercados Divisas Calculadora Divisas Materias Primas Carteras consenso ...

We are enthusiastic about the opportunity to become a leader in the rapidly evolving field of PTRT, and the first to begin clinical development of a peptide-targeted radionuclide therapy targeting ...